Bicocca Open Archive

Logo unimib boa
ARCANGELI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.619
EU - Europa 2.351
AS - Asia 607
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 1
Totale 8.587
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.561
IT - Italia 632
IE - Irlanda 617
DE - Germania 455
SE - Svezia 315
CN - Cina 283
HK - Hong Kong 245
GB - Regno Unito 117
UA - Ucraina 105
FR - Francia 58
CA - Canada 56
VN - Vietnam 38
IN - India 20
FI - Finlandia 13
DK - Danimarca 10
NL - Olanda 9
TR - Turchia 9
IR - Iran 4
ES - Italia 3
EU - Europa 3
GR - Grecia 3
ID - Indonesia 3
RO - Romania 3
RU - Federazione Russa 3
SA - Arabia Saudita 3
SC - Seychelles 3
AT - Austria 2
AU - Australia 2
MX - Messico 2
PL - Polonia 2
PT - Portogallo 2
BE - Belgio 1
BR - Brasile 1
CH - Svizzera 1
NZ - Nuova Zelanda 1
SG - Singapore 1
TH - Thailandia 1
Totale 8.587
Salva come PNG Salva come JPEG
Città #
Fairfield 1.047
Ann Arbor 823
Dublin 612
Ashburn 448
Frankfurt am Main 429
Woodbridge 429
Wilmington 402
Seattle 394
Cambridge 341
Houston 341
Hong Kong 245
Princeton 237
New York 183
Milan 138
Chandler 122
Lawrence 108
Altamura 107
Dearborn 89
Jacksonville 87
San Diego 69
Nanjing 67
Andover 41
Rome 36
Beijing 34
Toronto 28
Dong Ket 26
Ottawa 26
Hebei 24
Nanchang 22
Shenyang 22
London 21
Shanghai 18
Guangzhou 17
Jiaxing 14
Helsinki 12
Jinan 12
Lissone 12
Fremont 11
Pune 11
Redmond 10
Sulzano 10
Cologna Veneta 9
Norwalk 9
Changsha 8
Anzio 6
Los Angeles 6
Naples 6
Tianjin 6
Verona 6
Zhengzhou 6
Brescia 5
Cagliari 5
Chicago 5
Huizen 5
Kiev 5
Palermo 5
San Mateo 5
Bari 4
Berlin 4
Boardman 4
Chiswick 4
Falls Church 4
Fuzhou 4
Genoa 4
Hefei 4
Messina 4
Monza 4
Nave 4
Perugia 4
Amantea 3
Athens 3
Boulder 3
Bucharest 3
Dallas 3
Kocaeli 3
Leawood 3
Lonigo 3
Madrid 3
Mahé 3
Mountain View 3
Ningbo 3
Pisa 3
Southwark 3
Torino 3
Turin 3
Washington 3
Zanjan 3
Ankara 2
Antony 2
Bernareggio 2
Bollate 2
Carnago 2
Carovigno 2
Cedar Knolls 2
Coimbra 2
Concorezzo 2
Edingen-Neckarhausen 2
Empoli 2
Forlimpopoli 2
Hackney 2
Totale 7.350
Salva come PNG Salva come JPEG
Nome #
Effetti immunologici della radioterapia 307
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 251
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 242
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 230
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: A secondary analysis from a randomized study 183
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 165
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 156
Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study 143
Optimal scheduling of hypofractionated radiotherapy for localized prostate cancer: A systematic review and metanalysis of randomized clinical trials 133
Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy 125
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 120
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer 117
GUROPA survey: genito-urinary radiation oncology prescription attitudes 108
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area 107
Phase I-II study of intraoperative radiation therapy (IORT) after radical prostatectomy for prostate cancer 107
1539 poster TUMOR CONTROL PROBABILITY IN STEREOTACTIC RADIO-SURGERY FOR BRAIN METASTASES 107
Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer 104
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 102
Epidemiology of prostate cancer and treatment remarks. 101
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 101
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 101
Mathematical Model for Evaluating Incidence of Acute Rectal Toxicity During Conventional or Hypofractionated Radiotherapy Courses for Prostate Cancer 97
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial 97
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group 96
Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity 95
DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans 94
Moderate hypofractionation in high-risk, organ-confined prostate cancer: Final results of a phase III randomized trial 93
Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer 92
Hypofractionated radiotherapy for organ-confined prostate cancer: Is less more? 92
EORTC radiation proctitis-specific quality of life module - pretesting in four European countries 92
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 92
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer 91
Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC 90
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer 90
Clinical and Dosimetric Predictors of Acute Toxicity After a 4-Week Hypofractionated External Beam Radiotherapy Regimen for Prostate Cancer: Results From a Multicentric Prospective Trial 89
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC) 89
Color Doppler quantitative measures to predict outcome of biopsies in prostate cancer 88
Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials 88
Postoperative Hypofractionated Radiotherapy for Prostate Cancer 87
Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI 87
Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy? 87
Extreme hypofractionation for early prostate cancer: Biology meets technology 86
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 85
Moderate hypofractionation for prostate cancer 85
Updated Results and Pattern of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer 84
Stereotactic body radiation therapy salvage reirradiation of radiorecurrent prostatic carcinoma relapsed in the prostatic bed 83
Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO) 83
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease 83
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. 83
International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study 82
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era 81
Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours 80
Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: A further step toward new evidence 80
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery 80
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer 79
Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture? 79
Macroscopic Hematuria After Conventional or Hypofractionated Radiation Therapy: Results From a Prospective Phase 3 Study 79
Re-irradiation for esophageal cancer 79
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 78
A Systematic Review of Radical Cystectomy Versus Organ Preserving Trimodal Therapy in Muscle-Invasive Bladder Cancer 78
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 77
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 76
Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial 76
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments. 75
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments 74
Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control 74
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature 73
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: a potential comparison bias 73
Review and uses of stereotactic body radiation therapy for oligometastases 72
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: A review. 72
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study. 72
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 71
Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations 70
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review 70
Hypofractionation and Stereotactic Treatment: Clinical Data 69
Dose-escalated Radiotherapy for Stage III Unresectable Non-small Cell Lung Cancer: Have We Come to a Standstill? 69
Can volumetric modulated arc therapy with flattening filter free beams play a role in stereotactic body radiotherapy for liver lesions? A volume-based analysis. 69
From radiobiology to technology: what is changing in radiotherapy for prostate cancer 68
Is Hypofractionated (Chemo) radiation Delivered With Helical Tomotherapy a Feasible Option to Escalate the Dose in Locally- Advanced Inoperable NSCLC?: Results From a Phase 2 Trial 67
Vertebral metastases reirradiation with volumetric-modulated arc radiotherapy 65
Underlying anatomy for CTV contouring and lymphatic drainage in rectal cancer radiation therapy 62
Safety culture to improve accidental event reporting in radiotherapy 56
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 55
Stereotactic Body Radiation Therapy With Ablative Dose on Liver Metastases: Radiation-induced Liver Disease (RILD) and Toxicity Assessment 52
External beam radiation therapy in the treatment of the prostate adenocarcinoma in the elderly 52
Radiation therapy of breast cancer. Reasoned approach to a clinical case 51
Re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy 50
Dose and volume as predictive factors of pulmonary toxicity 50
Single fraction partial breast irradiation in prone position 47
High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience 46
Re: Cesare Cozzarini, Claudio Fiorino, Chiara Deantoni, et al. Higher-than-expected severe (grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients 44
Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study 42
Principi di Radioterapia 39
The role of palliative radiotherapy in the management of elderly and frail patients with advanced bladder cancer: A survey by the AIRO uro-group 39
Guidelines on prostate carcinoma - AIRO, 2016 37
Post-operative management of brain metastases: GRADE-based clinical practice recommendations on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 32
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy 32
Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking 32
A Multicenter Large Retrospective Database on the Personalization of Stereotactic Ablative Radiotherapy for Lung Metastases From Colon-Rectal Cancer: The LaIT-SABR Study 32
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 29
Totale 8.794
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019814 0 0 0 0 0 0 0 0 0 153 371 290
2019/20202.220 275 106 91 248 182 271 294 217 216 106 155 59
2020/20211.701 74 89 187 196 195 137 150 199 105 135 115 119
2021/20221.056 83 133 115 49 27 53 42 178 41 35 88 212
2022/20231.648 275 484 194 75 69 271 30 56 100 15 48 31
2023/20241.361 30 23 34 144 164 358 385 29 169 25 0 0
Totale 9.240